TNF and rheumatoid arthritis: For example, the IBD guideline advices on switching based on response to the TNFα inhibitor, drug concentrations and presence of antibodies,6 whereas the rheumatoid arthritis (RA) guideline does not provide a strategy in choosing between another TNFα inhibitor or to a biological drug belonging to another mechanistic class.7